Zoetis Inc. (ZTS: NYSE), the leading global animal health company, today celebrated its fifth anniversary since becoming a public company by hosting U.S. Secretary of Agriculture Sonny Perdue and Governor Rick Snyder of Michigan for a special town hall meeting at the company’s global research and development headquarters in Kalamazoo, Mich. Zoetis Chief Executive Officer Juan Ramón Alaix; Dr. Catherine Knupp, Executive Vice President and President, Research and Development; and Kristin Peck, Executive Vice President and President, U.S. Operations, led the event, which was attended by more than 500 colleagues.
Zoetis CEO Juan Ramón Alaix thanked Secretary Perdue and the U.S. Department of Agriculture (USDA) for its effective oversight of vaccines and biological therapeutics for animals. “We appreciate the leadership of the USDA in providing a strong regulatory framework that promotes innovation, and ensures the health and safety of animals as well as people,” said Mr. Alaix. “USDA has paved the way for continuous improvements in vaccine technology that help protect livestock and companion animals from endemic diseases.”
Alaix expressed appreciation to Governor Rick Snyder for creating a positive business climate that has made Michigan an attractive location for Zoetis’ global research and development headquarters and one of the largest manufacturing sites in its global manufacturing and supply network. He said that Michigan provides continued access to a highly skilled and diverse workforce which is essential to managing a global animal health company.
Also attending the 5th anniversary event were State Senator Margaret O’Brien, Michigan 20 th State Senate District; Jamie Clover Adams, Director Michigan Department of Agriculture and Rural Development accompanied by Gordon Wenk, Chief Deputy Director and Kenneth McFarlane, Deputy Director ; and Carl Bednarski, President, Michigan Farm Bureau.
Zoetis (NYSE:ZTS) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of US$4.9 billion with approximately 9,000 employees. For more information, visit www.Zoetis.com.